Skip to main content
Premium Trial:

Request an Annual Quote

Berg Enters CRADA for Prostate Cancer Biomarker Discovery

NEW YORK (GenomeWeb News) – Biopharmaceutical firm Berg and the US Department of Defense today announced an agreement to discover biomarkers for prostate cancer and to develop more effective treatments for the disease.

The deal is in the form of a Cooperative Research and Development agreement with the Uniformed Services University of the Health Sciences' Center for Prostate Disease Research (CPDR) and The Henry M. Jackson Foundation for the Advancement of Military Medicine.

Together, Berg and CPDR will "take a data-driven approach to drive molecular intelligence of prostate cancer by uncovering more accurate biomarkers and better therapies for patients."

Berg is offering its expertise in computational biology to the effort, as well as its Interrogative Biology Platform for the analysis of CPDR's supply of prostate cancer data.

Integrating molecular data directly from patients with clinical and demographic information, the platform can elucidate predictive patterns, providing clinicians with actionable information to inform their treatment decisions, Berg said.

According to Berg, about 238,590 men in the US were diagnosed with prostate cancer in 2012, and about 28,170 died of the disease.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.